Found: 6
Select item for more details and to access through your institution.
Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 286, doi. 10.1111/ejh.14114
- By:
- Publication type:
- Article
Real‐world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non‐interventional, post‐authorization safety study.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1259, doi. 10.1111/hae.14832
- By:
- Publication type:
- Article
Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications?
- Published in:
- International Journal of Women's Health, 2022, v. 14, p. 1307, doi. 10.2147/IJWH.S273043
- By:
- Publication type:
- Article
Acquired hemophilia A: emerging treatment options.
- Published in:
- Journal of Blood Medicine, 2015, v. 6, p. 143, doi. 10.2147/JBM.S77332
- By:
- Publication type:
- Article
Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
- Published in:
- Transfusion, 2015, v. 55, n. 1, p. 45, doi. 10.1111/trf.12784
- By:
- Publication type:
- Article
Bortezomib in Plasmablastic Lymphoma: A Case Report and Review of the Literature.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 5, p. 287, doi. 10.1159/000350325
- By:
- Publication type:
- Article